✦ LIBER ✦

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

✍ Scribed by James Chih-Hsin Yang; Jin-Yuan Shih; Wu-Chou Su; Te-Chun Hsia; Chun-Ming Tsai; Sai-Hong Ignatius Ou; Chung-Jen Yu; Gee-Chen Chang; Ching-Liang Ho; Lecia V Sequist; Arkadiusz Z Dudek; Mehdi Shahidi; Xiuyu Julie Cong; Robert M Lorence; Pan-Chyr Yang; Vincent A Miller

Book ID: 117786005
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 301 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70086-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal Growth Factor Receptor Mutatio

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

✍ Suehisa, H.; Toyooka, S.; Hotta, K.; Uchida, A.; Soh, J.; Fujiwara, Y.; Matsuo, 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 128 KB

Outcomes of Malaysian patients with adva

Outcomes of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor mutation status treated with gefitinib

✍ Chong-Kin LIAM; Muventhiran RUTHRANESAN; Chee-Hong LEE; Yong-Kek PANG; Keong-Tio 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Epidermal growth factor receptor, HER-2/

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features

✍ Erman, Mustafa; Grunenwald, Dominique; Penault-Llorca, Frederique; Grenier, Juli 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Cancer/testis antigen expression as a pr

Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma

✍ Baba, T.; Shiota, H.; Kuroda, K.; Shigematsu, Y.; Ichiki, Y.; Uramoto, H.; Hanag 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 144 KB

LUX-lung 3: A randomized, open-label, ph

LUX-lung 3: A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations

✍ Schuler, Martin; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O’Byrne, Ken; Hirsh, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Detection of epidermal growth factor rec

Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression

✍ Carlynn Willmore-Payne; Joseph A. Holden; Lester J. Layfield 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 547 KB